Moderna has agreed to pay Genevant Sciences, a subsidiary of Roivant Sciences, and Arbutus Biopharma up to $2.25 billion to settle a long-running legal fight over the technology that made its COVID-19 vaccine possible, the companies said on Tuesday. Under …
Nuclear Verdicts Go Boom, Increase 40.7% in 2025
So-called “nuclear” verdicts did not subside in 2025. In fact, it was quite the opposite. According to a new report from strategic communications and research